Advertisement

Approach to a Child with Epilepsy

  • Edward Kija
  • Jo M. WilmshurstEmail author
Chapter
  • 98 Downloads

Abstract

Epilepsies are very diverse conditions with marked variations in aetiology, clinical presentation and treatment outcome. Over the past decade, the understanding of epilepsy has made tremendous strides with the discovery of new genes and advanced imaging techniques. This has led to the 2010 International League Against Epilepsy (ILAE) re-organization of the classification of seizures and epilepsy syndromes. This current classification guides the investigations, treatment of seizures and the associated comorbid conditions in children with epilepsy and continues to evolve. This chapter covers the current classification of seizures and epilepsy syndromes. The management of a child presenting with epilepsy poses many challenges particularly in resource-limited settings. The chapter highlights a standard approach to the “workup” for a child presenting with seizures, associated comorbid conditions and treatment recommendations based on the current evidence-based practice. Additionally, the chapter provides a description of the common epilepsy syndromes and indications for referral to a paediatric neurologist.

References

  1. 1.
    WHO. World Health Organization. International Classification of Functioning Disability and Health: ICF. Geneva; 2001.Google Scholar
  2. 2.
    Leonardi M, Ustun TB. The global burden of epilepsy. Epilepsia. 2002;43(Suppl 6):21–5.PubMedCrossRefGoogle Scholar
  3. 3.
    Ngugi AK, Bottomley C, Kleinschmidt I, Sander JW, Newton CR. Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia. 2010;51:883–90.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Hauser WA. Epidemiology of epilepsy in children. Neurosurg Clin N Am. 1995;6:419–29.PubMedCrossRefGoogle Scholar
  5. 5.
    Camfield CS, Camfield PR, Gordon K, Wirrell E, Dooley JM. Incidence of epilepsy in childhood and adolescence: a population-based study in Nova Scotia from 1977 to 1985. Epilepsia. 1996;37:19–23.PubMedCrossRefGoogle Scholar
  6. 6.
    Wilmshurst JM, Berg AT, Lagae L, Newton CR, Cross JH. The challenges and innovations for therapy in children with epilepsy. Nat Rev Neurol. 2014;10:249–60.PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Newton CR, Garcia HH. Epilepsy in poor regions of the world. Lancet Lond Engl. 2012;380:1193–201.CrossRefGoogle Scholar
  8. 8.
    Wilmshurst JM, Birbeck GL, Newton CR. Epilepsy is ubiquitous, but more devastating in the poorer regions of the world... or is it? Epilepsia. 2014;55:1322–5.PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Flink R, et al. Guidelines for the use of EEG methodology in the diagnosis of epilepsy. International League Against Epilepsy: commission report. Commission on European Affairs: Subcommission on European Guidelines. Acta Neurol Scand. 2002;106:1–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Gaillard WD, et al. Guidelines for imaging infants and children with recent-onset epilepsy. Epilepsia. 2009;50:2147–53.PubMedCrossRefGoogle Scholar
  11. 11.
    Hirtz D, et al. Practice parameter: evaluating a first nonfebrile seizure in children: report of the quality standards subcommittee of the American Academy of Neurology, The Child Neurology Society, and The American Epilepsy Society. Neurology. 2000;55:616–23.PubMedCrossRefGoogle Scholar
  12. 12.
    Applegarth DA, Toone JR, Lowry RB. Incidence of inborn errors of metabolism in British Columbia, 1969–1996. Pediatrics. 2000;105:e10.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Dhamija R, Patterson MC, Wirrell EC. Epilepsy in children—when should we think neurometabolic disease? J Child Neurol. 2012;27:663–71.PubMedCrossRefGoogle Scholar
  14. 14.
    Dulac O, Plecko B, Gataullina S, Wolf NI. Occasional seizures, epilepsy, and inborn errors of metabolism. Lancet Neurol. 2014;13:727–39.PubMedCrossRefGoogle Scholar
  15. 15.
    Scheffer IE. Epilepsy genetics revolutionizes clinical practice. Neuropediatrics. 2014;45:70–4.PubMedCrossRefGoogle Scholar
  16. 16.
    Lemke JR, et al. Targeted next generation sequencing as a diagnostic tool in epileptic disorders. Epilepsia. 2012;53:1387–98.PubMedCrossRefGoogle Scholar
  17. 17.
    Ottman R, et al. Genetic testing in the epilepsies – report of the ILAE Genetics Commission. Epilepsia. 2010;51:655–70.PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Clancy RR. Summary proceedings from the neurology group on neonatal seizures. Pediatrics. 2006;117:S23–7.PubMedGoogle Scholar
  19. 19.
    Holmes GL, Khazipov R, Ben-Ari Y. New concepts in neonatal seizures. Neuroreport. 2002;13:A3–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Glass HC, Sullivan JE. Neonatal seizures. Curr Treat Options Neurol. 2009;11:405–13.PubMedCrossRefGoogle Scholar
  21. 21.
    Volpe JJ. Neonatal seizures: current concepts and revised classification. Pediatrics. 1989;84:422–8.PubMedGoogle Scholar
  22. 22.
    Korff C, Nordli DR. Do generalized tonic-clonic seizures in infancy exist? Neurology. 2005;65:1750–3.PubMedCrossRefGoogle Scholar
  23. 23.
    Steinlein OK, Conrad C, Weidner B. Benign familial neonatal convulsions: always benign? Epilepsy Res. 2007;73:245–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Panayiotopoulos CP. A clinical guide to epileptic syndromes and their treatment: Springer-Verlag; 2010.Google Scholar
  25. 25.
    Ohtahara S, Yamatogi Y. Ohtahara syndrome: with special reference to its developmental aspects for differentiating from early myoclonic encephalopathy. Epilepsy Res. 2006;70(Suppl 1):S58–67.PubMedCrossRefGoogle Scholar
  26. 26.
    Chien Y-H, et al. Poor outcome for neonatal-type nonketotic hyperglycinemia treated with high-dose sodium benzoate and dextromethorphan. J Child Neurol. 2004;19:39–42.PubMedCrossRefGoogle Scholar
  27. 27.
    Wang PJ, et al. The controversy regarding diagnostic criteria for early myoclonic encephalopathy. Brain and Development. 1998;20:530–5.PubMedCrossRefGoogle Scholar
  28. 28.
    Engel J, International League Against Epilepsy (ILAE). A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia. 2001;42:796–803.PubMedCrossRefGoogle Scholar
  29. 29.
    Cone TE. On a peculiar form of infantile convulsions (hypsarrhythmia) as described in his own infant son by Dr. W.J. West in 1841. Pediatrics. 1970;46:603.PubMedGoogle Scholar
  30. 30.
    Pellock JM, et al. Infantile spasms: a U. S. consensus report. Epilepsia. 2010;51:2175–89.PubMedCrossRefGoogle Scholar
  31. 31.
    Paciorkowski AR, Thio LL, Dobyns WB. Genetic and biologic classification of infantile spasms. Pediatr Neurol. 2011;45:355–67.PubMedPubMedCentralCrossRefGoogle Scholar
  32. 32.
    Krueger DA, Northrup H, International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013;49:255–65.PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Kothare SV, et al. Genotype/phenotype in tuberous sclerosis complex: associations with clinical and radiologic manifestations. Epilepsia. 2014;55:1020–4.PubMedCrossRefGoogle Scholar
  34. 34.
    Lux AL, et al. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol. 2005;4:712–7.PubMedCrossRefGoogle Scholar
  35. 35.
    Brunklaus A, Ellis R, Reavey E, Forbes GH, Zuberi SM. Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome. Brain J Neurol. 2012;135:2329–36.CrossRefGoogle Scholar
  36. 36.
    Sakauchi M, et al. Retrospective multiinstitutional study of the prevalence of early death in Dravet syndrome. Epilepsia. 2011;52:1144–9.PubMedCrossRefGoogle Scholar
  37. 37.
    Specchio N, et al. Electroencephalographic features in dravet syndrome: five-year follow-up study in 22 patients. J Child Neurol. 2012;27:439–44.PubMedCrossRefGoogle Scholar
  38. 38.
    Kassaï B, et al. Severe myoclonic epilepsy in infancy: a systematic review and a meta-analysis of individual patient data. Epilepsia. 2008;49:343–8.PubMedCrossRefGoogle Scholar
  39. 39.
    Chiron C, et al. Stiripentol in childhood partial epilepsy: randomized placebo-controlled trial with enrichment and withdrawal design. J Child Neurol. 2006;21:496–502.PubMedCrossRefGoogle Scholar
  40. 40.
    Agostinelli S, et al. Clinical dissection of early onset absence epilepsy in children and prognostic implications. Epilepsia. 2013;54:1761–70.PubMedCrossRefGoogle Scholar
  41. 41.
    Sadleir LG, Scheffer IE, Smith S, Connolly MB, Farrell K. Automatisms in absence seizures in children with idiopathic generalized epilepsy. Arch Neurol. 2009;66:729–34.PubMedCrossRefGoogle Scholar
  42. 42.
    Matricardi S, Verrotti A, Chiarelli F, Cerminara C, Curatolo P. Current advances in childhood absence epilepsy. Pediatr Neurol. 2014;50:205–12.PubMedCrossRefGoogle Scholar
  43. 43.
    Panayiotopoulos CP. The atlas of epilepsies: Springer; 2010.Google Scholar
  44. 44.
    Arzimanoglou A, et al. Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol. 2009;8:82–93.PubMedCrossRefGoogle Scholar
  45. 45.
    Camfield PR. Definition and natural history of Lennox-Gastaut syndrome. Epilepsia. 2011;52(Suppl 5):3–9.PubMedCrossRefGoogle Scholar
  46. 46.
    Montouris GD, Wheless JW, Glauser TA. The efficacy and tolerability of pharmacologic treatment options for Lennox-Gastaut syndrome. Epilepsia. 2014;55(Suppl 4):10–20.PubMedCrossRefGoogle Scholar
  47. 47.
    Kossoff EHW, Shields WD. Nonpharmacologic care for patients with Lennox-Gastaut syndrome: ketogenic diets and vagus nerve stimulation. Epilepsia. 2014;55(Suppl 4):29–33.PubMedCrossRefGoogle Scholar
  48. 48.
    Neubauer BA, Hahn A, Doose H, Tuxhorn I. Myoclonic-astatic epilepsy of early childhood – definition, course, nosography, and genetics. Adv Neurol. 2005;95:147–55.PubMedGoogle Scholar
  49. 49.
    Kelley SA, Kossoff EH. Doose syndrome (myoclonic-astatic epilepsy): 40 years of progress. Dev Med Child Neurol. 2010;52:988–93.PubMedCrossRefGoogle Scholar
  50. 50.
    Doose H. Myoclonic-astatic epilepsy. Epilepsy Res Suppl. 1992;6:163–8.PubMedGoogle Scholar
  51. 51.
    Tsai M-H, et al. Clinical genetic study of the epilepsy-aphasia spectrum. Epilepsia. 2013;54:280–7.PubMedCrossRefGoogle Scholar
  52. 52.
    Sánchez Fernández I, et al. Continuous spikes and waves during sleep: Electroclinical presentation and suggestions for management. Epilepsy Res Treat. 2013;2013:583531.PubMedPubMedCentralGoogle Scholar
  53. 53.
    Sánchez Fernández I, Loddenkemper T, Peters JM, Kothare SV. Electrical status epilepticus in sleep: clinical presentation and pathophysiology. Pediatr Neurol. 2012;47:390–410.PubMedCrossRefGoogle Scholar
  54. 54.
    Panayiotopoulos CP, Obeid T, Tahan AR. Juvenile myoclonic epilepsy: a 5-year prospective study. Epilepsia. 1994;35:285–96.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of Pediatrics and Child HealthMuhimbili University of Health and Allied SciencesDar Es SalaamTanzania
  2. 2.Department of Paediatric Neurology, Red Cross War Memorial Children’s Hospital, Neuroscience InstituteUniversity of Cape TownCape TownSouth Africa

Personalised recommendations